Retrophin Inc. | Key People and Executives
Stephen J. Aselage
President, Chief Executive Officer & Director
Roy D. Baynes
Independent Director
Ron Squarer
Independent Director
John A. Orwin
Independent Director
Jeffrey A. Meckler
Independent Director
John W. Kozarich
Independent Director
Timothy P. Coughlin
Independent Director
Stephen J. Aselage
President, Chief Executive Officer & Director
Neil F. McFarlane
Chief Operating Officer
Laura M. Clague
CFO, Principal Accounting Officer & Senior VP
Noah L. Rosenberg
Chief Medical Officer
William E. Rote
Senior VP, Head-Research & Development
H. Casey Logan
Vice President-Corporate Development
Chris Cline
VP-Investor Relations & Corporate Communications
Elizabeth E. Reed
Secretary, Senior Vice President & General Counsel
Roy D. Baynes
Independent Director
Ron Squarer
Independent Director
John A. Orwin
Independent Director
Jeffrey A. Meckler
Independent Director
John W. Kozarich
Independent Director
Timothy P. Coughlin
Independent Director
| Address |
3721 Valley Centre Drive
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.retrophin.com |
| Updated |
07/08/2019 |
| Retrophin, Inc. is a biopharmaceutical company, which engages in identifying, developing, and delivering therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA. |
